97 related articles for article (PubMed ID: 24206095)
1. Letting microRNAs overcome resistance to chemotherapy in acute myeloid leukemia.
Sakamoto KM
Leuk Lymphoma; 2014 Jul; 55(7):1449-50. PubMed ID: 24206095
[No Abstract] [Full Text] [Related]
2. MicroRNA let-7f is down-regulated in patients with refractory acute myeloid leukemia and is involved in chemotherapy resistance of adriamycin-resistant leukemic cells.
Dai CW; Bai QW; Zhang GS; Cao YX; Shen JK; Pei MF; Yin CC
Leuk Lymphoma; 2014 Jul; 55(7):1645-8. PubMed ID: 24067109
[No Abstract] [Full Text] [Related]
3. Expression of three different ATP-binding cassette transporters and correlation to chemoresistance in acute myeloid leukemia.
Palaiologou D; Panayiotidis P; Papanikolaou G; Georgiou G; Boutsikas G; Hatzinicolaou SL; Pangalis GA; Sakellaropoulos N; Vassilakopoulos TP; Angelopoulou MK
Int J Lab Hematol; 2015 Feb; 37(1):e7-e10. PubMed ID: 24809224
[No Abstract] [Full Text] [Related]
4. Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs.
Zebisch A; Hatzl S; Pichler M; Wölfler A; Sill H
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973410
[TBL] [Abstract][Full Text] [Related]
5. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1.
Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C
Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163
[TBL] [Abstract][Full Text] [Related]
6. Role and regulation of microRNAs targeting BTK in acute myelogenous leukemia.
Rizzotto L; Lai TH; Bottoni A; Woyach JA; Lapalombella R; Bloomfield CD; Byrd JC; Sampath D
Leuk Lymphoma; 2018 Jun; 59(6):1461-1465. PubMed ID: 28918688
[No Abstract] [Full Text] [Related]
7. MicroRNA expression-based outcome prediction in acute myeloid leukemia: novel insights through cross-platform integrative analyses.
Shivarov V; Dolnik A; Lang KM; Krönke J; Kuchenbauer F; Paschka P; Gaidzik VI; Döhner H; Schlenk RF; Döhner K; Bullinger L
Haematologica; 2016 Nov; 101(11):e454-e456. PubMed ID: 27470604
[No Abstract] [Full Text] [Related]
8. The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα.
Vargas Romero P; Cialfi S; Palermo R; De Blasio C; Checquolo S; Bellavia D; Chiaretti S; Foà R; Amadori A; Gulino A; Zardo G; Talora C; Screpanti I
Leukemia; 2015 Dec; 29(12):2442-5. PubMed ID: 25982911
[No Abstract] [Full Text] [Related]
9. MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia.
Krowiorz K; Ruschmann J; Lai C; Ngom M; Maetzig T; Martins V; Scheffold A; Schneider E; Pochert N; Miller C; Palmqvist L; Staffas A; Mulaw M; Bohl SR; Buske C; Heuser M; Kraus J; O'Neill K; Hansen CL; Petriv OI; Kestler H; Döhner H; Bullinger L; Döhner K; Humphries RK; Rouhi A; Kuchenbauer F
Blood Cancer J; 2016 Dec; 6(12):e508. PubMed ID: 27935579
[No Abstract] [Full Text] [Related]
10. Functional role of BAALC in leukemogenesis.
Heuser M; Berg T; Kuchenbauer F; Lai CK; Park G; Fung S; Lin G; Leung M; Krauter J; Ganser A; Humphries RK
Leukemia; 2012 Mar; 26(3):532-6. PubMed ID: 21869843
[No Abstract] [Full Text] [Related]
11. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
Tian C; Zheng G; Zhuang H; Li X; Hu D; Zhu L; Wang T; You MJ; Zhang Y
J Cell Physiol; 2017 Jun; 232(6):1387-1395. PubMed ID: 27696394
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA: an important regulator in acute myeloid leukemia.
Wang X; Chen H; Bai J; He A
Cell Biol Int; 2017 Sep; 41(9):936-945. PubMed ID: 28370893
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.
Testa U; Pelosi E
Leuk Lymphoma; 2015 May; 56(5):1466-74. PubMed ID: 25242094
[TBL] [Abstract][Full Text] [Related]
14. Genomic and transcriptomic profiles and in vitro resistance to mitoxantrone and idarubicin in pediatric acute leukemias.
Laskowska J; Lewandowska-Bieniek J; Szczepanek J; Styczyński J; Tretyn A
J Gene Med; 2016 Aug; 18(8):165-79. PubMed ID: 27280600
[TBL] [Abstract][Full Text] [Related]
15. miRNAs in acute myeloid leukemia.
Liao Q; Wang B; Li X; Jiang G
Oncotarget; 2017 Jan; 8(2):3666-3682. PubMed ID: 27705921
[TBL] [Abstract][Full Text] [Related]
16. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
Zhang S; Zhang Q; Shi G; Yin J
Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of microRNAs in chronic and acute human leukemia.
Yeh CH; Moles R; Nicot C
Mol Cancer; 2016 May; 15(1):37. PubMed ID: 27179712
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs: new players in AML pathogenesis.
Nicoloso MS; Jasra B; Calin GA
Cancer Treat Res; 2010; 145():169-81. PubMed ID: 20306251
[No Abstract] [Full Text] [Related]
19. Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.
Khalife J; Radomska HS; Santhanam R; Huang X; Neviani P; Saultz J; Wang H; Wu YZ; Alachkar H; Anghelina M; Dorrance A; Curfman J; Bloomfield CD; Medeiros BC; Perrotti D; Lee LJ; Lee RJ; Caligiuri MA; Pichiorri F; Croce CM; Garzon R; Guzman ML; Mendler JH; Marcucci G
Leukemia; 2015 Oct; 29(10):1981-92. PubMed ID: 25971362
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profiling in chemoresistant and chemosensitive acute myeloid leukemia.
Mosakhani N; Räty R; Tyybäkinoja A; Karjalainen-Lindsberg ML; Elonen E; Knuutila S
Cytogenet Genome Res; 2013; 141(4):272-6. PubMed ID: 23689423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
